Skip to content
OpenCapital
Get started

Prestige Consumer Healthcare PBH Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
——
Organon logo
OrganonOGN
——
Kenvue logo
KenvueKVUE
——

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S2×-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's debt instrument, unamortized discount (premium) and debt issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Prestige Consumer Healthcare (PBH) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of $6.45M in Q4 2025.
How has Prestige Consumer Healthcare's debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?
Prestige Consumer Healthcare's debt instrument, unamortized discount (premium) and debt issuance costs, net decreased by 19.6% year-over-year, from $8.03M to $6.45M.
What is the long-term trend for Prestige Consumer Healthcare's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Over 4 years (2021 to 2025), Prestige Consumer Healthcare's debt instrument, unamortized discount (premium) and debt issuance costs, net has grown at a -16.0% compound annual growth rate (CAGR), from $15.35M to $7.64M.